Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses EDITORIAL COMMENT

被引：0
|
作者：
Smoragiewicz, Martin [1 ]
Emmenegger, Urban [1 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF UROLOGY | 2021年 / 205卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1370 / 1370
页数：1
相关论文
共 50 条
  • [41] Addition of docetaxel or abiraterone to androgen deprivation therapy in metastatic hormone-sensitive prostate cancer in Indian population
    Gupta, Alok
    Hussain, Shaik Maheboob
    Sonthwal, Neha
    Chaturvedi, Harit
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (02) : 389 - 392
  • [42] Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone-sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study (vol 28, pg 765, 2021)
    Iguchi, T.
    Kimura, G.
    Fukasawa, S.
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (10) : 1079 - 1079
  • [43] Systemic Therapy for the Treatment of Hormone-Sensitive Metastatic Prostate Cancer: from Intermittent Androgen Deprivation Therapy to Chemotherapy
    Liaw, Bobby C.
    Shevach, Jeffrey
    Oh, William K.
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [44] Systemic Therapy for the Treatment of Hormone-Sensitive Metastatic Prostate Cancer: from Intermittent Androgen Deprivation Therapy to Chemotherapy
    Bobby C. Liaw
    Jeffrey Shevach
    William K. Oh
    Current Urology Reports, 2015, 16
  • [45] Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
    Armstrong, Andrew J.
    Azad, Arun A.
    Iguchi, Taro
    Szmulewitz, Russell Z.
    Petrylak, Daniel P.
    Holzbeierlein, Jeffrey
    Villers, Arnauld
    Alcaraz, Antonio
    Alekseev, Boris
    Shore, Neal D.
    Gomez-Veiga, Francisco
    Rosbrook, Brad
    Zohren, Fabian
    Yamada, Shunsuke
    Haas, Gabriel P.
    Stenzl, Arnulf
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (15) : 1616 - +
  • [46] Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study
    Stenzl, Arnulf
    Dunshee, Curtis
    De Giorgi, Ugo
    Alekseev, Boris
    Iguchi, Taro
    Szmulewitz, Russell Z.
    Flaig, Thomas W.
    Tombal, Bertrand
    Morlock, Robert
    Ivanescu, Cristina
    Ramaswamy, Krishnan
    Saad, Fred
    Armstrong, Andrew J.
    EUROPEAN UROLOGY, 2020, 78 (04) : 603 - 614
  • [47] Overall survival (OS) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) who received prior androgen deprivation therapy (ADT) and reached low prostate-specific antigen (PSA) levels treated further with enzalutamide (ENZA): Post hoc analyses of ARCHES
    Petrylak, D. P.
    Azad, A. A.
    Szmulewitz, R. Z.
    Iguchi, T.
    Shore, N. D.
    Holzbeierlein, J.
    Alekseev, B.
    El-Chaar, N. N.
    Rosbrook, B.
    Ma, J.
    Zohren, F.
    Haas, G. P.
    Stenzl, A.
    Armstrong, A. J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1183 - S1184
  • [48] Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy
    Gebrael, Georges
    Sayegh, Nicolas
    Chehade, Chadi Hage
    Jo, Yeonjung
    Narang, Arshit
    Chigarira, Beverly
    Tripathi, Nishita
    Srivastava, Ayana
    Tandar, Clara
    Williams, Jessica F.
    Garg, Diya
    Ji, Richard
    Maughan, Benjamin L.
    Swami, Umang
    Agarwal, Neeraj
    PROSTATE CANCER AND PROSTATIC DISEASES, 2025,
  • [49] Triple therapy in metastatic hormone-sensitive prostate cancer
    Tsaur, Igor
    Mirvald, Cristian
    Surcel, Cristian
    CURRENT OPINION IN UROLOGY, 2023, 33 (06) : 452 - 457
  • [50] Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Sweeney, Christopher J.
    Chen, Yu-Hui
    Carducci, Michael
    Liu, Glenn
    Jarrard, David F.
    Eisenberger, Mario
    Wong, Yu-Ning
    Hahn, Noah
    Kohli, Manish
    Cooney, Matthew M.
    Dreicer, Robert
    Vogelzang, Nicholas J.
    Picus, Joel
    Shevrin, Daniel
    Hussain, Maha
    Garcia, Jorge A.
    DiPaola, Robert S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 737 - 746
12345